Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
26
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Casale Donn | President and CEO, Director | 2 | $0 | $0 | 2026-10-01 |
| Smith Margaret Ekins | Chief Commercial Officer | 2 | $0 | $0 | 2026-09-01 |
| Kelly Michael | Director | 7 | $0 | $0 | 2026-06-24 |
| Dadoo Rajeev | Director | 5 | $0 | $0 | 2026-06-24 |
| Shah Pratik | Director, 10% Owner | 14 | $0 | $0 | 2026-06-24 |
| Islam Saqib | Director | 4 | $0 | $0 | 2026-06-24 |
| Shawver Laura | Director | 79 | $0 | $8.62M | 2026-06-24 |
| Kolchinsky Peter | Director, 10% Owner | 3 | $0 | $0 | 2026-06-24 |
| Thompson Peter A. | Director, 10% Owner | 10 | $3.10M | $12.59M | 2026-06-24 |
| SAUNDERS BRENT L | Director | 9 | $0 | $1.71M | 2026-06-24 |
| SCHNEIDER PHILLIP M | Director | 6 | $0 | $0 | 2026-06-24 |
| Karas Eric | Chief Commercial Officer | 29 | $0 | $1.31M | 2026-06-12 |
| Fitzpatrick Alexander A | Chief Legal Officer | 10 | $319.7K | $1.49M | 2026-06-12 |
| Tanimoto Sarina | Chief Medical Officer | 108 | $0 | $23.80M | 2026-01-02 |
| Chakma Justin | Chief Business Officer | 42 | $0 | $8.56M | 2026-01-02 |
| Scott Kathleen D. | Chief Financial Officer | 18 | $51.5K | $1.29M | 2026-01-02 |
| Dorsey Brian | Chief Operating Officer | 19 | $0 | $1.82M | 2026-01-02 |
| Lowenthal Richard E | President and CEO | 107 | $0 | $23.82M | 2026-01-02 |
| Flynn James E | 10% Owner | 2 | $0 | $13.66M | 2025-06-27 |
| Deerfield Private Design Fund III, L.P. | 10% Owner | 8 | $0 | $10.14M | 2024-11-12 |
| ORBIMED CAPITAL LLC | Director | 5 | $0 | $12.59M | 2024-08-26 |
| RA Capital Healthcare Fund LP | Director, 10% Owner | 3 | $8.18M | $0 | 2024-06-20 |
| Pratik Shah Living Trust dated June 15, 2011 | 10% Owner | 1 | $0 | $0 | 2024-06-04 |
| RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | 4 | $36.54M | $0 | 2024-03-27 |
| OrbiMed Capital GP VI LLC | Director | 1 | $3.10M | $0 | 2023-08-29 |
| Shah Rajeev M. | Director | 2 | $0 | $0 | 2022-11-08 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Casale Donn | President and CEO, Director | A Award deriv | 2026-10-01 | 2026-10-05 | 1,036,923 | — | $0 | 1,036,923 | SEC↗ |
| Smith Margaret Ekins | Chief Commercial Officer | A Award deriv | 2026-09-01 | 2026-09-02 | 1,001,738 | — | $0 | 1,001,738 | SEC↗ |
| Smith Margaret Ekins | Chief Commercial Officer | A Award deriv | 2026-09-01 | 2026-09-02 | 1,001,738 | — | $0 | 1,001,738 | SEC↗ |
| Casale Donn | President | A Award deriv | 2026-07-01 | 2026-07-02 | 898,456 | — | $0 | 898,456 | SEC↗ |
| Shawver Laura | Director | A Award deriv | 2026-06-24 | 2026-06-26 | 30,000 | — | $0 | 30,000 | SEC↗ |
| SCHNEIDER PHILLIP M | Director | A Award deriv | 2026-06-24 | 2026-06-26 | 30,000 | — | $0 | 30,000 | SEC↗ |
| SAUNDERS BRENT L | Director | A Award deriv | 2026-06-24 | 2026-06-26 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Thompson Peter A. | Director | A Award deriv | 2026-06-24 | 2026-06-26 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Islam Saqib | Director | A Award deriv | 2026-06-24 | 2026-06-26 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Kelly Michael | Director | A Award deriv | 2026-06-24 | 2026-06-26 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Shah Pratik | Director | A Award deriv | 2026-06-24 | 2026-06-26 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Dadoo Rajeev | Director | A Award deriv | 2026-06-24 | 2026-06-26 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Kolchinsky Peter | Director, 10% Owner | A Award deriv | 2026-06-24 | 2026-06-26 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Karas Eric | Chief Commercial Officer | M Exercise deriv | 2026-06-12 | 2026-06-12 | 25,000 | — | $0 | 519,588 | SEC↗ |
| Fitzpatrick Alexander A | Chief Legal Officer | S Sale | 2026-06-12 | 2026-06-12 | 3,355 | $10.00 | $33.5K | 90,910 | SEC↗ |
| Karas Eric | Chief Commercial Officer | S Sale | 2026-06-12 | 2026-06-12 | 25,000 | $10.00 | $250.0K | 12,176 | SEC↗ |
| Karas Eric | Chief Commercial Officer | M Exercise | 2026-06-12 | 2026-06-12 | 25,000 | $1.50 | $37.5K | 37,176 | SEC↗ |
| Lowenthal Richard E | PRESIDENT AND CEO | A Award deriv | 2026-01-02 | 2026-01-05 | 875,000 | — | $0 | 875,000 | SEC↗ |
| Lowenthal Richard E | PRESIDENT AND CEO | A Award deriv | 2026-01-02 | 2026-01-05 | 240,000 | — | $0 | 240,000 | SEC↗ |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | A Award deriv | 2026-01-02 | 2026-01-05 | 875,000 | — | $0 | 875,000 | SEC↗ |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | A Award deriv | 2026-01-02 | 2026-01-05 | 240,000 | — | $0 | 240,000 | SEC↗ |
| Chakma Justin | Chief Business Officer | A Award deriv | 2026-01-02 | 2026-01-05 | 240,000 | — | $0 | 240,000 | SEC↗ |
| Dorsey Brian | Chief Operating Officer | A Award deriv | 2026-01-02 | 2026-01-05 | 240,000 | — | $0 | 240,000 | SEC↗ |
| Fitzpatrick Alexander A | Chief Legal Officer | A Award deriv | 2026-01-02 | 2026-01-05 | 240,000 | — | $0 | 240,000 | SEC↗ |
| Karas Eric | Chief Commercial Officer | A Award deriv | 2026-01-02 | 2026-01-05 | 240,000 | — | $0 | 240,000 | SEC↗ |
| Scott Kathleen D. | Chief Financial Officer | A Award deriv | 2026-01-02 | 2026-01-05 | 240,000 | — | $0 | 240,000 | SEC↗ |
| Dorsey Brian | Chief Operating Officer | M Exercise deriv | 2025-11-13 | 2025-11-14 | 21,828 | — | $0 | 0 | SEC↗ |
| Dorsey Brian | Chief Operating Officer | S Sale | 2025-11-13 | 2025-11-14 | 21,828 | $8.71 | $190.1K | 10,789 | SEC↗ |
| Dorsey Brian | Chief Operating Officer | M Exercise | 2025-11-13 | 2025-11-14 | 21,828 | $0.64 | $14.0K | 32,617 | SEC↗ |
| Chakma Justin | Chief Business Officer | M Exercise deriv | 2025-11-12 | 2025-11-14 | 30,000 | — | $0 | 89,047 | SEC↗ |
| Shah Pratik | Director | G Gift | 2025-11-12 | 2025-11-14 | 250,000 | — | $0 | 4,574,554 | SEC↗ |
| Shah Pratik | Director | G Gift | 2025-11-12 | 2025-11-14 | 100,000 | — | $0 | 4,474,554 | SEC↗ |
| Chakma Justin | Chief Business Officer | M Exercise | 2025-11-12 | 2025-11-14 | 30,000 | $0.84 | $25.2K | 166,380 | SEC↗ |
| Chakma Justin | Chief Business Officer | S Sale | 2025-11-12 | 2025-11-14 | 30,000 | $8.91 | $267.3K | 136,380 | SEC↗ |
| Chakma Justin | Chief Business Officer | S Sale | 2025-11-12 | 2025-11-14 | 136,380 | $8.86 | $1.21M | 0 | SEC↗ |
| Scott Kathleen D. | Chief Financial Officer | M Exercise deriv | 2025-08-21 | 2025-08-22 | 12,500 | — | $0 | 739,830 | SEC↗ |
| Scott Kathleen D. | Chief Financial Officer | S Sale | 2025-08-21 | 2025-08-22 | 12,500 | $15.00 | $187.5K | 10,042 | SEC↗ |
| Scott Kathleen D. | Chief Financial Officer | M Exercise | 2025-08-21 | 2025-08-22 | 12,500 | $1.50 | $18.8K | 22,542 | SEC↗ |
| Lowenthal Richard E | PRESIDENT AND CEO | S Sale | 2025-08-21 | 2025-08-22 | 50,000 | $14.49 | $724.5K | 1,196,494 | SEC↗ |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | S Sale | 2025-08-20 | 2025-08-21 | 37,656 | $14.09 | $530.6K | 1,247,447 | SEC↗ |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | S Sale | 2025-08-19 | 2025-08-21 | 12,344 | $14.03 | $173.2K | 1,285,103 | SEC↗ |
| Karas Eric | Chief Commercial Officer | M Exercise deriv | 2025-07-01 | 2025-07-03 | 15,000 | — | $0 | 544,588 | SEC↗ |
| Karas Eric | Chief Commercial Officer | S Sale | 2025-07-01 | 2025-07-03 | 15,000 | $16.99 | $254.8K | 10,315 | SEC↗ |
| Karas Eric | Chief Commercial Officer | M Exercise | 2025-07-01 | 2025-07-03 | 15,000 | $1.50 | $22.5K | 25,315 | SEC↗ |
| Flynn James E | 10% Owner | S Sale | 2025-06-27 | 2025-07-01 | 370,075 | $18.46 | $6.83M | 4,887,254 | SEC↗ |
| Flynn James E | 10% Owner | S Sale | 2025-06-27 | 2025-07-01 | 370,074 | $18.46 | $6.83M | 4,887,254 | SEC↗ |
| Shawver Laura | Director | A Award deriv | 2025-06-25 | 2025-06-27 | 30,000 | — | $0 | 30,000 | SEC↗ |
| SCHNEIDER PHILLIP M | Director | A Award deriv | 2025-06-25 | 2025-06-27 | 30,000 | — | $0 | 30,000 | SEC↗ |
| SAUNDERS BRENT L | Director | A Award deriv | 2025-06-25 | 2025-06-27 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Islam Saqib | Director | A Award deriv | 2025-06-25 | 2025-06-27 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Shah Pratik | Director | A Award deriv | 2025-06-25 | 2025-06-27 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Thompson Peter A. | Director | A Award deriv | 2025-06-25 | 2025-06-27 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Kelly Michael | Director | A Award deriv | 2025-06-25 | 2025-06-27 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Dadoo Rajeev | Director | A Award deriv | 2025-06-25 | 2025-06-27 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Kolchinsky Peter | Director, 10% Owner | A Award deriv | 2025-06-25 | 2025-06-27 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Karas Eric | Chief Commercial Officer | M Exercise deriv | 2025-06-18 | 2025-06-20 | 15,000 | — | $0 | 559,588 | SEC↗ |
| Karas Eric | Chief Commercial Officer | M Exercise | 2025-06-18 | 2025-06-20 | 15,000 | $1.50 | $22.5K | 22,696 | SEC↗ |
| Karas Eric | Chief Commercial Officer | S Sale | 2025-06-18 | 2025-06-20 | 15,000 | $16.00 | $240.0K | 7,696 | SEC↗ |
| Scott Kathleen D. | Chief Financial Officer | M Exercise deriv | 2025-05-20 | 2025-05-22 | 50,000 | — | $0 | 752,330 | SEC↗ |
| SAUNDERS BRENT L | Director | M Exercise deriv | 2025-05-20 | 2025-05-22 | 120,000 | — | $0 | 470,950 | SEC↗ |
| Fitzpatrick Alexander A | Chief Legal Officer | M Exercise deriv | 2025-05-20 | 2025-05-22 | 100,000 | — | $0 | 200,000 | SEC↗ |
| Scott Kathleen D. | Chief Financial Officer | S Sale | 2025-05-20 | 2025-05-22 | 50,000 | $14.10 | $705.0K | 7,424 | SEC↗ |
| Scott Kathleen D. | Chief Financial Officer | M Exercise | 2025-05-20 | 2025-05-22 | 50,000 | $1.50 | $75.0K | 57,424 | SEC↗ |
| SAUNDERS BRENT L | Director | S Sale | 2025-05-20 | 2025-05-22 | 120,000 | $14.25 | $1.71M | 0 | SEC↗ |
| SAUNDERS BRENT L | Director | M Exercise | 2025-05-20 | 2025-05-22 | 120,000 | $1.01 | $121.2K | 120,000 | SEC↗ |
| Fitzpatrick Alexander A | Chief Legal Officer | S Sale | 2025-05-20 | 2025-05-22 | 102,969 | $14.10 | $1.45M | 89,613 | SEC↗ |
| Fitzpatrick Alexander A | Chief Legal Officer | M Exercise | 2025-05-20 | 2025-05-22 | 100,000 | $5.58 | $558.0K | 192,582 | SEC↗ |
| Shawver Laura | Director | M Exercise deriv | 2025-04-07 | 2025-04-08 | 27,493 | — | $0 | 24,062 | SEC↗ |
| Shawver Laura | Director | M Exercise deriv | 2025-04-07 | 2025-04-08 | 22,509 | — | $0 | 51,555 | SEC↗ |
| Shawver Laura | Director | S Sale | 2025-04-07 | 2025-04-08 | 50,002 | $12.30 | $615.0K | 210,346 | SEC↗ |
| Shawver Laura | Director | M Exercise | 2025-04-07 | 2025-04-08 | 27,493 | $4.85 | $133.3K | 260,348 | SEC↗ |
| Shawver Laura | Director | M Exercise | 2025-04-07 | 2025-04-08 | 22,509 | $4.85 | $109.2K | 232,855 | SEC↗ |
| Karas Eric | Chief Commercial Officer | M Exercise deriv | 2025-03-20 | 2025-03-21 | 10,000 | — | $0 | 574,588 | SEC↗ |
| Karas Eric | Chief Commercial Officer | S Sale | 2025-03-20 | 2025-03-21 | 10,000 | $14.00 | $140.0K | 7,696 | SEC↗ |
| Karas Eric | Chief Commercial Officer | M Exercise | 2025-03-20 | 2025-03-21 | 10,000 | $1.50 | $15.0K | 17,696 | SEC↗ |
| Shawver Laura | Director | M Exercise deriv | 2025-03-06 | 2025-03-07 | 49,600 | — | $0 | 74,064 | SEC↗ |
| Shawver Laura | Director | M Exercise | 2025-03-06 | 2025-03-07 | 49,600 | $4.85 | $240.6K | 259,946 | SEC↗ |
| Shawver Laura | Director | S Sale | 2025-03-06 | 2025-03-07 | 49,600 | $11.21 | $556.0K | 210,346 | SEC↗ |
| Shawver Laura | Director | M Exercise deriv | 2025-03-05 | 2025-03-07 | 400 | — | $0 | 123,664 | SEC↗ |
| Shawver Laura | Director | S Sale | 2025-03-05 | 2025-03-07 | 400 | $11.00 | $4.4K | 210,346 | SEC↗ |
| Shawver Laura | Director | M Exercise | 2025-03-05 | 2025-03-07 | 400 | $4.85 | $1.9K | 210,746 | SEC↗ |
| Shawver Laura | Director | M Exercise deriv | 2025-02-03 | 2025-02-04 | 9,064 | — | $0 | 0 | SEC↗ |
| Shawver Laura | Director | M Exercise deriv | 2025-02-03 | 2025-02-04 | 40,936 | — | $0 | 124,064 | SEC↗ |
| Shawver Laura | Director | M Exercise | 2025-02-03 | 2025-02-04 | 9,064 | $3.15 | $28.6K | 219,410 | SEC↗ |
| Shawver Laura | Director | S Sale | 2025-02-03 | 2025-02-04 | 50,000 | $12.31 | $615.5K | 210,346 | SEC↗ |
| Shawver Laura | Director | M Exercise | 2025-02-03 | 2025-02-04 | 40,936 | $4.85 | $198.5K | 260,346 | SEC↗ |
| Shawver Laura | Director | M Exercise deriv | 2025-01-06 | 2025-01-07 | 50,000 | — | $0 | 9,064 | SEC↗ |
| Shawver Laura | Director | S Sale | 2025-01-06 | 2025-01-07 | 50,000 | $11.10 | $555.0K | 210,346 | SEC↗ |
| Shawver Laura | Director | M Exercise | 2025-01-06 | 2025-01-07 | 50,000 | $3.15 | $157.5K | 260,346 | SEC↗ |
| Karas Eric | Chief Commercial Officer | A Award deriv | 2025-01-02 | 2025-01-03 | 152,300 | — | $0 | 152,300 | SEC↗ |
| Scott Kathleen D. | Chief Financial Officer | A Award deriv | 2025-01-02 | 2025-01-03 | 176,700 | — | $0 | 176,700 | SEC↗ |
| Chakma Justin | Chief Business Officer | A Award deriv | 2025-01-02 | 2025-01-03 | 274,100 | — | $0 | 274,100 | SEC↗ |
| Dorsey Brian | Chief Operating Officer | A Award deriv | 2025-01-02 | 2025-01-03 | 261,900 | — | $0 | 261,900 | SEC↗ |
| Fitzpatrick Alexander A | Chief Legal Officer | A Award deriv | 2025-01-02 | 2025-01-03 | 152,300 | — | $0 | 152,300 | SEC↗ |
| Lowenthal Richard E | PRESIDENT AND CEO | A Award deriv | 2025-01-02 | 2025-01-03 | 767,600 | — | $0 | 767,600 | SEC↗ |
| Lowenthal Richard E | PRESIDENT AND CEO | A Award deriv | 2025-01-02 | 2025-01-03 | 261,900 | — | $0 | 261,900 | SEC↗ |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | A Award deriv | 2025-01-02 | 2025-01-03 | 767,600 | — | $0 | 767,600 | SEC↗ |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | A Award deriv | 2025-01-02 | 2025-01-03 | 261,900 | — | $0 | 261,900 | SEC↗ |
| Lowenthal Richard E | PRESIDENT AND CEO | S Sale | 2024-12-17 | 2024-12-19 | 50,000 | $11.67 | $583.5K | 1,297,447 | SEC↗ |
| Lowenthal Richard E | PRESIDENT AND CEO | S Sale | 2024-12-17 | 2024-12-19 | 50,000 | $11.67 | $583.5K | 1,098,499 | SEC↗ |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | S Sale | 2024-12-17 | 2024-12-19 | 50,000 | $11.67 | $583.5K | 1,098,499 | SEC↗ |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | S Sale | 2024-12-17 | 2024-12-19 | 50,000 | $11.67 | $583.5K | 1,297,447 | SEC↗ |
| Chakma Justin | Chief Business Officer | M Exercise deriv | 2024-12-13 | 2024-12-13 | 27,272 | — | $0 | 55,461 | SEC↗ |
| Chakma Justin | Chief Business Officer | M Exercise | 2024-12-13 | 2024-12-13 | 27,272 | $1.44 | $39.3K | 163,652 | SEC↗ |
| Chakma Justin | Chief Business Officer | S Sale | 2024-12-13 | 2024-12-13 | 27,272 | $12.06 | $328.9K | 136,380 | SEC↗ |
| Dorsey Brian | Chief Operating Officer | M Exercise deriv | 2024-12-12 | 2024-12-13 | 25,000 | — | $0 | 21,828 | SEC↗ |
| Chakma Justin | Chief Business Officer | M Exercise deriv | 2024-12-12 | 2024-12-13 | 117,333 | — | $0 | 119,047 | SEC↗ |
| Dorsey Brian | Chief Operating Officer | S Sale | 2024-12-12 | 2024-12-13 | 25,000 | $12.30 | $307.5K | 6,024 | SEC↗ |
| Dorsey Brian | Chief Operating Officer | M Exercise | 2024-12-12 | 2024-12-13 | 25,000 | $0.64 | $16.0K | 31,024 | SEC↗ |
| Chakma Justin | Chief Business Officer | S Sale | 2024-12-12 | 2024-12-13 | 117,333 | $12.27 | $1.44M | 136,380 | SEC↗ |
| Chakma Justin | Chief Business Officer | M Exercise | 2024-12-12 | 2024-12-13 | 117,333 | $0.84 | $98.6K | 253,713 | SEC↗ |
| Dorsey Brian | Chief Operating Officer | M Exercise deriv | 2024-12-11 | 2024-12-13 | 15,000 | — | $0 | 46,828 | SEC↗ |
| Dorsey Brian | Chief Operating Officer | S Sale | 2024-12-11 | 2024-12-13 | 15,000 | $12.43 | $186.4K | 6,024 | SEC↗ |
| Dorsey Brian | Chief Operating Officer | M Exercise | 2024-12-11 | 2024-12-13 | 15,000 | $0.64 | $9.6K | 21,024 | SEC↗ |
| Chakma Justin | Chief Business Officer | M Exercise deriv | 2024-12-10 | 2024-12-12 | 50,000 | — | $0 | 0 | SEC↗ |
| Lowenthal Richard E | PRESIDENT AND CEO | S Sale | 2024-12-10 | 2024-12-11 | 50,000 | $13.17 | $658.5K | 1,246,494 | SEC↗ |
| Lowenthal Richard E | PRESIDENT AND CEO | S Sale | 2024-12-10 | 2024-12-11 | 50,000 | $13.16 | $658.0K | 1,148,499 | SEC↗ |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | S Sale | 2024-12-10 | 2024-12-11 | 50,000 | $13.16 | $658.0K | 1,148,499 | SEC↗ |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | S Sale | 2024-12-10 | 2024-12-11 | 50,000 | $13.17 | $658.5K | 1,246,494 | SEC↗ |
| Chakma Justin | Chief Business Officer | S Sale | 2024-12-10 | 2024-12-12 | 50,000 | $13.15 | $657.5K | 136,380 | SEC↗ |
| Chakma Justin | Chief Business Officer | M Exercise | 2024-12-10 | 2024-12-12 | 50,000 | $0.84 | $42.0K | 186,380 | SEC↗ |
| Chakma Justin | Chief Business Officer | M Exercise deriv | 2024-12-06 | 2024-12-06 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Lowenthal Richard E | PRESIDENT AND CEO | M Exercise deriv | 2024-12-06 | 2024-12-09 | 11,876 | — | $0 | 1,088,124 | SEC↗ |
| Lowenthal Richard E | PRESIDENT AND CEO | M Exercise deriv | 2024-12-06 | 2024-12-09 | 13,789 | — | $0 | 20,684 | SEC↗ |
| Lowenthal Richard E | PRESIDENT AND CEO | M Exercise deriv | 2024-12-06 | 2024-12-09 | 11,876 | — | $0 | 338,124 | SEC↗ |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | M Exercise deriv | 2024-12-06 | 2024-12-09 | 13,789 | — | $0 | 20,684 | SEC↗ |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | M Exercise deriv | 2024-12-06 | 2024-12-09 | 11,876 | — | $0 | 338,124 | SEC↗ |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | M Exercise deriv | 2024-12-06 | 2024-12-09 | 11,876 | — | $0 | 1,088,124 | SEC↗ |
| Chakma Justin | Chief Business Officer | S Sale | 2024-12-06 | 2024-12-06 | 50,000 | $14.23 | $711.5K | 136,380 | SEC↗ |
| Chakma Justin | Chief Business Officer | M Exercise | 2024-12-06 | 2024-12-06 | 50,000 | $0.84 | $42.0K | 186,380 | SEC↗ |
| Lowenthal Richard E | PRESIDENT AND CEO | M Exercise | 2024-12-06 | 2024-12-09 | 11,876 | $8.42 | $100.0K | 3,433,512 | SEC↗ |
| Lowenthal Richard E | PRESIDENT AND CEO | M Exercise | 2024-12-06 | 2024-12-09 | 13,789 | $1.44 | $19.9K | 3,421,636 | SEC↗ |
| Lowenthal Richard E | PRESIDENT AND CEO | M Exercise | 2024-12-06 | 2024-12-09 | 11,876 | $8.42 | $100.0K | 4,327,189 | SEC↗ |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | M Exercise | 2024-12-06 | 2024-12-09 | 11,876 | $8.42 | $100.0K | 3,433,512 | SEC↗ |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | M Exercise | 2024-12-06 | 2024-12-09 | 11,876 | $8.42 | $100.0K | 4,327,189 | SEC↗ |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | M Exercise | 2024-12-06 | 2024-12-09 | 13,789 | $1.44 | $19.9K | 3,421,636 | SEC↗ |
| Chakma Justin | Chief Business Officer | M Exercise deriv | 2024-12-05 | 2024-12-06 | 49,640 | — | $0 | 100,000 | SEC↗ |
| Chakma Justin | Chief Business Officer | M Exercise | 2024-12-05 | 2024-12-06 | 49,640 | $0.84 | $41.7K | 186,020 | SEC↗ |
| Chakma Justin | Chief Business Officer | S Sale | 2024-12-05 | 2024-12-06 | 49,640 | $14.13 | $701.4K | 136,380 | SEC↗ |
| Karas Eric | Chief Commercial Officer | M Exercise deriv | 2024-12-04 | 2024-12-04 | 6,283 | — | $0 | 584,588 | SEC↗ |
| Shawver Laura | Director | M Exercise deriv | 2024-12-04 | 2024-12-04 | 14,772 | — | $0 | 59,064 | SEC↗ |
| Chakma Justin | Chief Business Officer | M Exercise deriv | 2024-12-04 | 2024-12-06 | 45,000 | — | $0 | 149,640 | SEC↗ |
| Karas Eric | Chief Commercial Officer | M Exercise | 2024-12-04 | 2024-12-04 | 6,283 | $1.50 | $9.4K | 11,976 | SEC↗ |
| Karas Eric | Chief Commercial Officer | S Sale | 2024-12-04 | 2024-12-04 | 6,283 | $14.00 | $88.0K | 5,693 | SEC↗ |
| Shawver Laura | Director | M Exercise | 2024-12-04 | 2024-12-04 | 14,772 | $3.15 | $46.5K | 225,118 | SEC↗ |
| Shawver Laura | Director | S Sale | 2024-12-04 | 2024-12-04 | 14,772 | $13.75 | $203.1K | 210,346 | SEC↗ |
| Chakma Justin | Chief Business Officer | M Exercise | 2024-12-04 | 2024-12-06 | 45,000 | $0.84 | $37.8K | 181,380 | SEC↗ |
| Chakma Justin | Chief Business Officer | S Sale | 2024-12-04 | 2024-12-06 | 45,000 | $13.95 | $627.8K | 136,380 | SEC↗ |
| Shawver Laura | Director | M Exercise deriv | 2024-12-03 | 2024-12-04 | 25,606 | — | $0 | 0 | SEC↗ |
| Shawver Laura | Director | M Exercise deriv | 2024-12-03 | 2024-12-04 | 62,378 | — | $0 | 73,836 | SEC↗ |
| Chakma Justin | Chief Business Officer | M Exercise deriv | 2024-12-03 | 2024-12-04 | 41,740 | — | $0 | 194,640 | SEC↗ |
| Chakma Justin | Chief Business Officer | M Exercise deriv | 2024-12-03 | 2024-12-04 | 3,260 | — | $0 | 0 | SEC↗ |
| Shawver Laura | Director | S Sale | 2024-12-03 | 2024-12-04 | 87,984 | $13.26 | $1.17M | 210,346 | SEC↗ |
| Shawver Laura | Director | M Exercise | 2024-12-03 | 2024-12-04 | 62,378 | $3.15 | $196.5K | 298,330 | SEC↗ |
| Shawver Laura | Director | M Exercise | 2024-12-03 | 2024-12-04 | 25,606 | $1.27 | $32.5K | 235,952 | SEC↗ |
| Chakma Justin | Chief Business Officer | M Exercise | 2024-12-03 | 2024-12-04 | 41,740 | $0.84 | $35.1K | 181,380 | SEC↗ |
| Chakma Justin | Chief Business Officer | M Exercise | 2024-12-03 | 2024-12-04 | 3,260 | $0.84 | $2.7K | 139,640 | SEC↗ |
| Chakma Justin | Chief Business Officer | S Sale | 2024-12-03 | 2024-12-04 | 45,000 | $13.19 | $593.5K | 136,380 | SEC↗ |
| Karas Eric | Chief Commercial Officer | M Exercise deriv | 2024-12-02 | 2024-12-04 | 3,717 | — | $0 | 590,871 | SEC↗ |
| Shawver Laura | Director | M Exercise deriv | 2024-12-02 | 2024-12-04 | 29,628 | — | $0 | 25,606 | SEC↗ |
| Shawver Laura | Director | M Exercise deriv | 2024-12-02 | 2024-12-04 | 67,616 | — | $0 | 0 | SEC↗ |
| Chakma Justin | Chief Business Officer | M Exercise deriv | 2024-12-02 | 2024-12-04 | 45,000 | — | $0 | 3,260 | SEC↗ |
| Karas Eric | Chief Commercial Officer | M Exercise | 2024-12-02 | 2024-12-04 | 3,717 | $1.50 | $5.6K | 9,410 | SEC↗ |
| Karas Eric | Chief Commercial Officer | S Sale | 2024-12-02 | 2024-12-04 | 3,717 | $14.11 | $52.4K | 5,693 | SEC↗ |
| Shawver Laura | Director | M Exercise | 2024-12-02 | 2024-12-04 | 29,628 | $1.27 | $37.6K | 307,590 | SEC↗ |
| Shawver Laura | Director | S Sale | 2024-12-02 | 2024-12-04 | 901 | $14.34 | $12.9K | 210,346 | SEC↗ |
| Shawver Laura | Director | S Sale | 2024-12-02 | 2024-12-04 | 96,343 | $13.55 | $1.31M | 211,247 | SEC↗ |
| Shawver Laura | Director | M Exercise | 2024-12-02 | 2024-12-04 | 67,616 | $1.27 | $85.9K | 277,962 | SEC↗ |
| Chakma Justin | Chief Business Officer | S Sale | 2024-12-02 | 2024-12-04 | 45,000 | $13.67 | $615.1K | 136,380 | SEC↗ |
| Chakma Justin | Chief Business Officer | M Exercise | 2024-12-02 | 2024-12-04 | 45,000 | $0.84 | $37.8K | 181,380 | SEC↗ |
| Chakma Justin | Chief Business Officer | S Sale | 2024-11-27 | 2024-11-27 | 25,000 | $14.39 | $359.8K | 136,380 | SEC↗ |
| Chakma Justin | Chief Business Officer | S Sale | 2024-11-26 | 2024-11-27 | 42,186 | $14.05 | $592.7K | 161,380 | SEC↗ |
| Chakma Justin | Chief Business Officer | S Sale | 2024-11-25 | 2024-11-27 | 32,814 | $14.00 | $459.4K | 203,566 | SEC↗ |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | S Sale | 2024-11-19 | 2024-11-21 | 50,000 | $13.95 | $697.5K | 1,347,447 | SEC↗ |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | S Sale | 2024-11-19 | 2024-11-21 | 50,000 | $13.95 | $697.5K | 1,198,499 | SEC↗ |
| Lowenthal Richard E | PRESIDENT AND CEO | S Sale | 2024-11-19 | 2024-11-21 | 50,000 | $13.95 | $697.5K | 1,198,499 | SEC↗ |
| Lowenthal Richard E | PRESIDENT AND CEO | S Sale | 2024-11-19 | 2024-11-21 | 50,000 | $13.95 | $697.5K | 1,347,447 | SEC↗ |
| Deerfield Private Design Fund | 10% Owner | S Sale | 2024-11-12 | 2024-11-13 | 9,554 | $17.77 | $169.8K | 5,257,329 | SEC↗ |
| Deerfield Private Design Fund | 10% Owner | S Sale | 2024-11-12 | 2024-11-13 | 7,854 | $17.16 | $134.8K | 5,266,881 | SEC↗ |
| Deerfield Private Design Fund | 10% Owner | S Sale | 2024-11-12 | 2024-11-13 | 7,853 | $17.16 | $134.8K | 5,266,883 | SEC↗ |
| Deerfield Private Design Fund | 10% Owner | S Sale | 2024-11-12 | 2024-11-13 | 9,553 | $17.77 | $169.8K | 5,257,328 | SEC↗ |
| Lowenthal Richard E | PRESIDENT AND CEO | S Sale | 2024-11-12 | 2024-11-14 | 4,876 | $17.64 | $86.0K | 1,248,499 | SEC↗ |
| Lowenthal Richard E | PRESIDENT AND CEO | S Sale | 2024-11-12 | 2024-11-14 | 45,124 | $16.76 | $756.3K | 1,253,375 | SEC↗ |
| Lowenthal Richard E | PRESIDENT AND CEO | S Sale | 2024-11-12 | 2024-11-14 | 4,955 | $17.64 | $87.4K | 1,296,494 | SEC↗ |
| Lowenthal Richard E | PRESIDENT AND CEO | S Sale | 2024-11-12 | 2024-11-14 | 45,045 | $16.76 | $755.0K | 1,301,449 | SEC↗ |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | S Sale | 2024-11-12 | 2024-11-14 | 4,955 | $17.64 | $87.4K | 1,296,494 | SEC↗ |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | S Sale | 2024-11-12 | 2024-11-14 | 45,124 | $16.76 | $756.3K | 1,253,375 | SEC↗ |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | S Sale | 2024-11-12 | 2024-11-14 | 4,876 | $17.64 | $86.0K | 1,248,499 | SEC↗ |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | S Sale | 2024-11-12 | 2024-11-14 | 45,045 | $16.76 | $755.0K | 1,301,449 | SEC↗ |
| Deerfield Private Design Fund | 10% Owner | S Sale | 2024-11-11 | 2024-11-13 | 223,632 | $18.15 | $4.06M | 5,274,735 | SEC↗ |
| Deerfield Private Design Fund | 10% Owner | S Sale | 2024-11-11 | 2024-11-13 | 223,632 | $18.15 | $4.06M | 5,274,736 | SEC↗ |
| Deerfield Private Design Fund | 10% Owner | S Sale | 2024-11-11 | 2024-11-13 | 40,596 | $17.45 | $708.4K | 5,498,367 | SEC↗ |
| Deerfield Private Design Fund | 10% Owner | S Sale | 2024-11-11 | 2024-11-13 | 40,596 | $17.45 | $708.4K | 5,498,368 | SEC↗ |
| Scott Kathleen D. | Chief Financial Officer | M Exercise deriv | 2024-10-16 | 2024-10-17 | 12,500 | — | $0 | 802,330 | SEC↗ |
| Scott Kathleen D. | Chief Financial Officer | M Exercise | 2024-10-16 | 2024-10-17 | 12,500 | $1.50 | $18.8K | 17,449 | SEC↗ |
| Scott Kathleen D. | Chief Financial Officer | S Sale | 2024-10-16 | 2024-10-17 | 12,500 | $16.00 | $200.0K | 4,949 | SEC↗ |
| Lowenthal Richard E | PRESIDENT AND CEO | S Sale | 2024-10-15 | 2024-10-17 | 48,550 | $14.86 | $721.5K | 1,398,897 | SEC↗ |
| Lowenthal Richard E | PRESIDENT AND CEO | S Sale | 2024-10-15 | 2024-10-17 | 50,000 | $14.88 | $744.0K | 1,298,499 | SEC↗ |
| Lowenthal Richard E | PRESIDENT AND CEO | S Sale | 2024-10-15 | 2024-10-17 | 1,450 | $15.25 | $22.1K | 1,397,447 | SEC↗ |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | S Sale | 2024-10-15 | 2024-10-17 | 1,450 | $15.25 | $22.1K | 1,397,447 | SEC↗ |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | S Sale | 2024-10-15 | 2024-10-17 | 48,550 | $14.86 | $721.5K | 1,398,897 | SEC↗ |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | S Sale | 2024-10-15 | 2024-10-17 | 50,000 | $14.88 | $744.0K | 1,298,499 | SEC↗ |
| Lowenthal Richard E | PRESIDENT AND CEO | S Sale | 2024-10-08 | 2024-10-10 | 50,000 | $13.83 | $691.5K | 1,348,499 | SEC↗ |
| Lowenthal Richard E | PRESIDENT AND CEO | S Sale | 2024-10-08 | 2024-10-10 | 50,000 | $13.83 | $691.5K | 1,346,494 | SEC↗ |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | S Sale | 2024-10-08 | 2024-10-10 | 50,000 | $13.83 | $691.5K | 1,348,499 | SEC↗ |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | S Sale | 2024-10-08 | 2024-10-10 | 50,000 | $13.83 | $691.5K | 1,346,494 | SEC↗ |
| Karas Eric | Chief Commercial Officer | M Exercise deriv | 2024-09-18 | 2024-09-19 | 10,000 | — | $0 | 594,588 | SEC↗ |
| Karas Eric | Chief Commercial Officer | M Exercise | 2024-09-18 | 2024-09-19 | 10,000 | $1.50 | $15.0K | 15,693 | SEC↗ |
| Karas Eric | Chief Commercial Officer | S Sale | 2024-09-18 | 2024-09-19 | 10,000 | $14.00 | $140.0K | 5,693 | SEC↗ |
| Lowenthal Richard E | PRESIDENT AND CEO | S Sale | 2024-09-17 | 2024-09-19 | 50,000 | $12.93 | $646.5K | 1,398,499 | SEC↗ |
| Lowenthal Richard E | PRESIDENT AND CEO | S Sale | 2024-09-17 | 2024-09-19 | 50,000 | $12.93 | $646.5K | 1,447,447 | SEC↗ |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | S Sale | 2024-09-17 | 2024-09-19 | 50,000 | $12.93 | $646.5K | 1,447,447 | SEC↗ |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | S Sale | 2024-09-17 | 2024-09-19 | 50,000 | $12.93 | $646.5K | 1,398,499 | SEC↗ |
| Lowenthal Richard E | PRESIDENT AND CEO | S Sale | 2024-09-10 | 2024-09-12 | 50,000 | $11.50 | $575.0K | 1,448,499 | SEC↗ |
| Lowenthal Richard E | PRESIDENT AND CEO | S Sale | 2024-09-10 | 2024-09-12 | 50,000 | $11.50 | $575.0K | 1,396,494 | SEC↗ |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | S Sale | 2024-09-10 | 2024-09-12 | 50,000 | $11.50 | $575.0K | 1,396,494 | SEC↗ |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | S Sale | 2024-09-10 | 2024-09-12 | 50,000 | $11.50 | $575.0K | 1,448,499 | SEC↗ |
| ORBIMED CAPITAL LLC | Director | S Sale | 2024-08-26 | 2024-08-28 | 83,695 | $13.00 | $1.09M | 0 | SEC↗ |
| Thompson Peter A. | Director | S Sale | 2024-08-26 | 2024-08-28 | 83,695 | $13.00 | $1.09M | 0 | SEC↗ |
| ORBIMED CAPITAL LLC | Director | S Sale | 2024-08-23 | 2024-08-23 | 69,500 | $13.03 | $905.6K | 83,695 | SEC↗ |
| Thompson Peter A. | Director | S Sale | 2024-08-23 | 2024-08-23 | 69,500 | $13.03 | $905.6K | 83,695 | SEC↗ |
| ORBIMED CAPITAL LLC | Director | S Sale | 2024-08-22 | 2024-08-23 | 391,482 | $12.94 | $5.07M | 153,195 | SEC↗ |
| Thompson Peter A. | Director | S Sale | 2024-08-22 | 2024-08-23 | 391,482 | $12.94 | $5.07M | 153,195 | SEC↗ |
| ORBIMED CAPITAL LLC | Director | S Sale | 2024-08-21 | 2024-08-23 | 13,300 | $14.61 | $194.3K | 544,677 | SEC↗ |
| ORBIMED CAPITAL LLC | Director | S Sale | 2024-08-21 | 2024-08-23 | 394,400 | $13.52 | $5.33M | 557,977 | SEC↗ |
| Thompson Peter A. | Director | S Sale | 2024-08-21 | 2024-08-23 | 394,400 | $13.52 | $5.33M | 557,977 | SEC↗ |
| Thompson Peter A. | Director | S Sale | 2024-08-21 | 2024-08-23 | 13,300 | $14.61 | $194.3K | 544,677 | SEC↗ |
| Scott Kathleen D. | Chief Financial Officer | M Exercise deriv | 2024-08-20 | 2024-08-21 | 12,500 | — | $0 | 814,830 | SEC↗ |
| Dorsey Brian | Chief Operating Officer | M Exercise deriv | 2024-08-20 | 2024-08-21 | 50,000 | — | $0 | 61,828 | SEC↗ |
| Lowenthal Richard E | PRESIDENT AND CEO | S Sale | 2024-08-20 | 2024-08-21 | 2,300 | $16.26 | $37.4K | 1,497,447 | SEC↗ |
| Lowenthal Richard E | PRESIDENT AND CEO | S Sale | 2024-08-20 | 2024-08-21 | 11,523 | $15.62 | $180.0K | 1,500,760 | SEC↗ |
| Lowenthal Richard E | PRESIDENT AND CEO | S Sale | 2024-08-20 | 2024-08-21 | 36,216 | $14.76 | $534.5K | 1,512,283 | SEC↗ |
| Lowenthal Richard E | PRESIDENT AND CEO | S Sale | 2024-08-20 | 2024-08-21 | 2,261 | $16.25 | $36.7K | 1,498,499 | SEC↗ |
| Lowenthal Richard E | PRESIDENT AND CEO | S Sale | 2024-08-20 | 2024-08-21 | 11,756 | $15.61 | $183.5K | 1,499,747 | SEC↗ |
| Lowenthal Richard E | PRESIDENT AND CEO | S Sale | 2024-08-20 | 2024-08-21 | 35,944 | $14.76 | $530.5K | 1,511,503 | SEC↗ |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | S Sale | 2024-08-20 | 2024-08-21 | 11,756 | $15.61 | $183.5K | 1,499,747 | SEC↗ |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | S Sale | 2024-08-20 | 2024-08-21 | 2,261 | $16.25 | $36.7K | 1,498,499 | SEC↗ |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | S Sale | 2024-08-20 | 2024-08-21 | 36,216 | $14.76 | $534.5K | 1,512,283 | SEC↗ |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | S Sale | 2024-08-20 | 2024-08-21 | 2,300 | $16.26 | $37.4K | 1,497,447 | SEC↗ |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | S Sale | 2024-08-20 | 2024-08-21 | 11,523 | $15.62 | $180.0K | 1,500,760 | SEC↗ |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | S Sale | 2024-08-20 | 2024-08-21 | 35,944 | $14.76 | $530.5K | 1,511,503 | SEC↗ |
| Scott Kathleen D. | Chief Financial Officer | S Sale | 2024-08-20 | 2024-08-21 | 12,500 | $16.00 | $200.0K | 13,199 | SEC↗ |
| Scott Kathleen D. | Chief Financial Officer | M Exercise | 2024-08-20 | 2024-08-21 | 12,500 | $1.50 | $18.8K | 25,699 | SEC↗ |
| Dorsey Brian | Chief Operating Officer | S Sale | 2024-08-20 | 2024-08-21 | 50,000 | $15.00 | $750.0K | 6,024 | SEC↗ |
| Dorsey Brian | Chief Operating Officer | M Exercise | 2024-08-20 | 2024-08-21 | 50,000 | $0.64 | $32.0K | 56,024 | SEC↗ |
| Karas Eric | Chief Commercial Officer | M Exercise deriv | 2024-08-19 | 2024-08-21 | 10,000 | — | $0 | 604,588 | SEC↗ |
| Karas Eric | Chief Commercial Officer | S Sale | 2024-08-19 | 2024-08-21 | 10,000 | $14.00 | $140.0K | 5,693 | SEC↗ |
| Karas Eric | Chief Commercial Officer | M Exercise | 2024-08-19 | 2024-08-21 | 10,000 | $1.50 | $15.0K | 15,693 | SEC↗ |
| Dorsey Brian | Chief Operating Officer | M Exercise deriv | 2024-08-13 | 2024-08-15 | 30,000 | — | $0 | 111,828 | SEC↗ |
| Lowenthal Richard E | PRESIDENT AND CEO | S Sale | 2024-08-13 | 2024-08-15 | 14,599 | $11.78 | $172.0K | 1,481,895 | SEC↗ |
| Lowenthal Richard E | PRESIDENT AND CEO | S Sale | 2024-08-13 | 2024-08-15 | 35,401 | $12.76 | $451.7K | 1,446,494 | SEC↗ |
| Lowenthal Richard E | PRESIDENT AND CEO | S Sale | 2024-08-13 | 2024-08-15 | 14,637 | $11.77 | $172.3K | 1,583,862 | SEC↗ |
| Lowenthal Richard E | PRESIDENT AND CEO | S Sale | 2024-08-13 | 2024-08-15 | 35,363 | $12.77 | $451.6K | 1,548,499 | SEC↗ |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | S Sale | 2024-08-13 | 2024-08-15 | 35,401 | $12.76 | $451.7K | 1,446,494 | SEC↗ |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | S Sale | 2024-08-13 | 2024-08-15 | 14,599 | $11.78 | $172.0K | 1,481,895 | SEC↗ |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | S Sale | 2024-08-13 | 2024-08-15 | 14,637 | $11.77 | $172.3K | 1,583,862 | SEC↗ |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | S Sale | 2024-08-13 | 2024-08-15 | 35,363 | $12.77 | $451.6K | 1,548,499 | SEC↗ |
| Dorsey Brian | Chief Operating Officer | M Exercise | 2024-08-13 | 2024-08-15 | 30,000 | $0.64 | $19.2K | 36,024 | SEC↗ |
| Dorsey Brian | Chief Operating Officer | S Sale | 2024-08-13 | 2024-08-15 | 30,000 | $13.00 | $390.0K | 6,024 | SEC↗ |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | S Sale | 2024-07-16 | 2024-07-18 | 50,000 | $11.40 | $570.0K | 1,598,499 | SEC↗ |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | S Sale | 2024-07-16 | 2024-07-18 | 50,000 | $11.40 | $570.0K | 1,547,447 | SEC↗ |
| Lowenthal Richard E | PRESIDENT AND CEO | S Sale | 2024-07-16 | 2024-07-18 | 50,000 | $11.40 | $570.0K | 1,598,499 | SEC↗ |
| Lowenthal Richard E | PRESIDENT AND CEO | S Sale | 2024-07-16 | 2024-07-18 | 50,000 | $11.40 | $570.0K | 1,547,447 | SEC↗ |
| Lowenthal Richard E | PRESIDENT AND CEO | S Sale | 2024-07-09 | 2024-07-11 | 50,000 | $9.62 | $481.0K | 1,496,494 | SEC↗ |
| Lowenthal Richard E | PRESIDENT AND CEO | S Sale | 2024-07-09 | 2024-07-11 | 50,000 | $9.62 | $481.0K | 1,648,499 | SEC↗ |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | S Sale | 2024-07-09 | 2024-07-11 | 50,000 | $9.62 | $481.0K | 1,648,499 | SEC↗ |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | S Sale | 2024-07-09 | 2024-07-11 | 50,000 | $9.62 | $481.0K | 1,496,494 | SEC↗ |
| SAUNDERS BRENT L | Director | A Award deriv | 2024-06-20 | 2024-06-24 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Thompson Peter A. | Director | A Award deriv | 2024-06-20 | 2024-06-24 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Kelly Michael | Director | A Award deriv | 2024-06-20 | 2024-06-24 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Islam Saqib | Director | A Award deriv | 2024-06-20 | 2024-06-24 | 40,000 | — | $0 | 40,000 | SEC↗ |
| SCHNEIDER PHILLIP M | Director | A Award deriv | 2024-06-20 | 2024-06-24 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Shah Pratik | Director | A Award deriv | 2024-06-20 | 2024-06-24 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Shawver Laura | Director | A Award deriv | 2024-06-20 | 2024-06-24 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Dadoo Rajeev | Director | A Award deriv | 2024-06-20 | 2024-06-24 | 40,000 | — | $0 | 40,000 | SEC↗ |
| RA Capital Healthcare Fund LP | Director, 10% Owner | A Award deriv | 2024-06-20 | 2024-06-24 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Shah Pratik | Director | G Gift | 2024-06-13 | 2024-06-17 | 200,000 | — | $0 | 1,132,900 | SEC↗ |
| Shah Pratik | Director | G Gift | 2024-06-13 | 2024-06-17 | 1,132,900 | — | $0 | 0 | SEC↗ |
| Lowenthal Richard E | PRESIDENT AND CEO | S Sale | 2024-06-12 | 2024-06-13 | 47,834 | $9.15 | $437.7K | 1,546,494 | SEC↗ |
| Lowenthal Richard E | PRESIDENT AND CEO | S Sale | 2024-06-12 | 2024-06-13 | 48,028 | $9.14 | $439.0K | 1,698,499 | SEC↗ |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | S Sale | 2024-06-12 | 2024-06-13 | 47,834 | $9.15 | $437.7K | 1,546,494 | SEC↗ |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | S Sale | 2024-06-12 | 2024-06-13 | 48,028 | $9.14 | $439.0K | 1,698,499 | SEC↗ |
| Lowenthal Richard E | PRESIDENT AND CEO | S Sale | 2024-06-11 | 2024-06-13 | 2,166 | $9.00 | $19.5K | 1,594,328 | SEC↗ |
| Lowenthal Richard E | PRESIDENT AND CEO | S Sale | 2024-06-11 | 2024-06-13 | 1,972 | $9.00 | $17.7K | 1,746,527 | SEC↗ |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | S Sale | 2024-06-11 | 2024-06-13 | 2,166 | $9.00 | $19.5K | 1,594,328 | SEC↗ |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | S Sale | 2024-06-11 | 2024-06-13 | 1,972 | $9.00 | $17.7K | 1,746,527 | SEC↗ |
| Shah Pratik | Director, 10% Owner | G Gift | 2024-06-07 | 2024-06-07 | 1,332,950 | — | $0 | 4,824,554 | SEC↗ |
| Shah Pratik | Director, 10% Owner | G Gift | 2024-06-04 | 2024-06-06 | 1,332,900 | — | $0 | 6,157,504 | SEC↗ |
| Shah Pratik | Director, 10% Owner | G Gift | 2024-06-04 | 2024-06-06 | 1,332,900 | — | $0 | 1,332,900 | SEC↗ |
| Shah Pratik | Director, 10% Owner | J Other | 2024-06-04 | 2024-06-06 | 2,665,800 | — | $0 | 7,490,404 | SEC↗ |
| Pratik Shah Living Trust dated | 10% Owner | J Other | 2024-06-04 | 2024-06-07 | 2,665,800 | — | $0 | 7,490,404 | SEC↗ |
| Lowenthal Richard E | PRESIDENT AND CEO | S Sale | 2024-05-16 | 2024-05-16 | 44,350 | $9.06 | $401.8K | 1,748,499 | SEC↗ |
| Lowenthal Richard E | PRESIDENT AND CEO | S Sale | 2024-05-16 | 2024-05-16 | 44,746 | $9.06 | $405.4K | 1,597,447 | SEC↗ |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | S Sale | 2024-05-16 | 2024-05-16 | 44,746 | $9.06 | $405.4K | 1,597,447 | SEC↗ |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | S Sale | 2024-05-16 | 2024-05-16 | 44,350 | $9.06 | $401.8K | 1,748,499 | SEC↗ |
| Lowenthal Richard E | PRESIDENT AND CEO | S Sale | 2024-05-15 | 2024-05-16 | 2,766 | $9.04 | $25.0K | 1,792,849 | SEC↗ |
| Lowenthal Richard E | PRESIDENT AND CEO | S Sale | 2024-05-15 | 2024-05-16 | 2,381 | $9.05 | $21.5K | 1,642,193 | SEC↗ |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | S Sale | 2024-05-15 | 2024-05-16 | 2,381 | $9.05 | $21.5K | 1,642,193 | SEC↗ |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | S Sale | 2024-05-15 | 2024-05-16 | 2,766 | $9.04 | $25.0K | 1,792,849 | SEC↗ |
| Lowenthal Richard E | PRESIDENT AND CEO | S Sale | 2024-05-14 | 2024-05-16 | 2,884 | $9.01 | $26.0K | 1,795,615 | SEC↗ |